Markers of cerebral damage during delirium in elderly patients with hip fracture.
about
Recent Insights on Prevalence and Corelations of Hypoactive DeliriumBiomarkers of Brain Damage and Postoperative Cognitive Disorders in Orthopedic Patients: An UpdateBiomarkers of postoperative delirium and cognitive dysfunctionBiomarkers for delirium--a reviewThe American Geriatrics Society/National Institute on Aging Bedside-to-Bench Conference: Research Agenda on Delirium in Older Adults.Effects of nimodipine on postoperative delirium in elderly under general anesthesia: A prospective, randomized, controlled clinical trial.Optimal therapeutic dose and time window of picroside II in cerebral ischemic injury.Acetylcholinesterase inhibitors reduce neuroinflammation and -degeneration in the cortex and hippocampus of a surgery stress rat model.The Johns Hopkins Delirium Consortium: a model for collaborating across disciplines and departments for delirium prevention and treatment.Role of peripheral inflammatory markers in postoperative cognitive dysfunction (POCD): a meta-analysisReview of Postoperative Delirium in Geriatric Patients Undergoing Hip SurgeryS100 calcium binding protein B as a biomarker of delirium duration in the intensive care unit - an exploratory analysis.Should general anaesthesia be avoided in the elderly?Delirium-biomarkers and genetic variance.Peripheral biomarkers of stroke: Focus on circulatory microRNAsAdmission plasma levels of the neuronal injury marker neuron-specific enolase are associated with mortality and delirium in sepsis.Effect of Hemin on Brain Alterations and Neuroglobin Expression in Water Immersion Restraint Stressed Rats.Unraveling the Relationship Between Delirium, Brain Damage, and Subsequent Cognitive Decline in a Cohort of Individuals Undergoing Surgery for Hip Fracture.Serum galectin-3 levels and delirium among postpartum intensive care unit women.Delirium in the ICU: an overview.Assessment of serum S100B and neuron specific enolase levels to evaluate the neurotoxıc effects of organıc solvent exposure.Cerebrospinal Fluid Phosphate in Delirium after Hip Fracture.Serum S100B protein could help to detect cerebral complications associated with extracorporeal membrane oxygenation (ECMO).β-asarone and levodopa co-administration increase striatal dopamine level in 6-hydroxydopamine induced rats by modulating P-glycoprotein and tight junction proteins at the blood-brain barrier and promoting levodopa into the brain.Cerebrospinal Fluid S100B and Alzheimer's Disease Biomarkers in Hip Fracture Patients with Delirium.Baden Prevention and Reduction of Incidence of Postoperative Delirium Trial (PRIDe): a phase IV multicenter, randomized, placebo-controlled, double-blind clinical trial of ketamine versus haloperidol for prevention of postoperative delirium.A Pilot Study of the Use of Dexmedetomidine for the Control of Delirium by Reducing the Serum Concentrations of Brain-Derived Neurotrophic Factor, Neuron-Specific Enolase, and S100B in Polytrauma Patients.Temporal biomarker profiles and their association with ICU acquired delirium: a cohort study.
P2860
Q26782925-8F3DBEE2-8A85-4857-B113-CD65D3517336Q26784577-74018043-E122-451A-953E-114BD1BF67D9Q26830796-FC08CAEC-7254-4D59-B259-330A47AD6A9CQ27025577-DCEC564D-97DC-4116-8D94-9CB05EA707ABQ33610107-BD1B6949-2601-411C-A2DA-D737633CFF0DQ33672772-A39D8C44-384E-451C-A15F-48B5F365A079Q34319468-F49B05B4-9043-41FF-A534-F60FA2B9D467Q34720755-59B9C480-4DD7-47B3-B1DA-250F3D6EF73EQ35009421-1384CFF7-8AAA-42BF-AF29-3189839AC65DQ35043861-7C705AC8-E736-4617-ABE0-8F54EFFCA203Q36914844-F974A740-723B-49C4-90F2-8E1FA3D964E2Q37373277-174A2A73-16A3-4EFF-80E4-EBB2762F7C68Q37551462-05B02D94-D23C-451B-87CC-F0056B00F921Q38921528-EB1D0A31-74D3-4735-ABF1-BBA7E2939A97Q38922418-4E0F9A86-72EC-41C2-A940-CC630F4A87BAQ38933525-91BA0C1F-2F18-44D2-A0CB-93F3C7630F44Q39706128-058DAD78-8152-4673-A012-E3E9B90EA6D8Q40536346-9D3FAF7C-0943-4D50-A84B-E853424F6DE9Q41449179-83E04A75-0D6F-45B2-A4F1-A995B38C9DC2Q42574905-CA109F51-D094-4810-9DE0-E72EB4767504Q45012044-62BB379C-6D20-405E-91E3-9276474A6E65Q47155600-1E98B27D-52EA-4AD7-85AB-BAC0F620EFCFQ47995515-7FB00745-1924-417A-95DB-5B16954F1D7EQ48825282-108296E3-AA41-44CA-87B1-7B49684F00A5Q49163640-8A24934E-D7A2-46C1-81F1-6B48411109F0Q50335104-C9AF6601-D2A5-4ECF-B046-BC0DC4222073Q50966405-7E9AF454-6A22-4E0F-85C2-008BFD928A21Q54962258-02F7D6C2-6644-42BD-9531-25D1DEC67392
P2860
Markers of cerebral damage during delirium in elderly patients with hip fracture.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Markers of cerebral damage during delirium in elderly patients with hip fracture.
@ast
Markers of cerebral damage during delirium in elderly patients with hip fracture.
@en
type
label
Markers of cerebral damage during delirium in elderly patients with hip fracture.
@ast
Markers of cerebral damage during delirium in elderly patients with hip fracture.
@en
prefLabel
Markers of cerebral damage during delirium in elderly patients with hip fracture.
@ast
Markers of cerebral damage during delirium in elderly patients with hip fracture.
@en
P2093
P2860
P356
P1433
P1476
Markers of cerebral damage during delirium in elderly patients with hip fracture.
@en
P2093
Aeilko H Zwinderman
Barbara C van Munster
Catharina M Korse
Johanna C Korevaar
Johannes M Bonfrer
Sophia E de Rooij
P2860
P2888
P356
10.1186/1471-2377-9-21
P577
2009-05-27T00:00:00Z
P5875
P6179
1031647105